$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Shanghai, China, 1992-1995 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10No. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
C00Lip422665.485.81650.055.4547121481.077.692.882.248.5
C01-02Tongue20610954.861.59752.259.7372849623082.180.759.848.946.6
C03-06Oral cavity28516546.457.412063.171.53019711016477.481.763.962.550.7
C07-08Salivary gland18910860.969.98172.677.9503139492092.976.469.158.955.6
C09Tonsil593842.651.12170.676.7811151411100.944.264.447.861.3
C11Nasopharynx106077148.152.428961.965.23312092771895464.160.055.441.640.1
C12-13Hypopharynx372825.031.4922.224.83271690.052.131.730.035.4
C15Oesophagus2988200113.216.698712.815.071108649128287825.723.720.116.410.7
C16Stomach11735767025.230.6406524.127.1112686925684306286644.743.135.126.417.3
C17Small intestine22914226.130.28720.623.3282558803835.945.726.824.416.8
C18Colon4782240441.550.6237844.550.64633761245170998955.658.354.051.339.8
C19-20Rectum3284183840.148.4144641.646.8396324835110562450.254.550.949.833.8
C21Anus934237.546.95140.548.16922322450.745.960.344.239.5
C22Liver695449527.99.120026.47.398480818042106125212.210.09.08.05.1
C23-24Gall bladder138351012.515.787312.814.9617429059336538.121.015.612.314.9
C25Pancreas224212136.78.410296.27.19514750089260817.19.37.87.36.9
C30-31Nose/Sinuses20012840.146.47249.655.8411450603546.451.465.345.738.8
C32Larynx62455550.161.26948.856.1234216627312057.474.472.759.241.8
C33-34Lung141041017812.615.6392611.913.753475633416073340019.721.719.413.910.2
C37-38Other thoracic organs40326630.434.213736.539.510039781256152.649.742.025.710.4
C40-41Bone52326827.931.125526.729.0134407915611459.538.627.116.310.8
C43Melanoma skin1105246.254.95842.248.413826352854.677.171.544.329.9
C44Other skin47225766.383.021573.389.0483510514713788.585.585.484.887.6
C47+C49Connective tissue48227557.363.920755.860.3165601021005571.175.561.548.445.8
C50Breast51845872.188.3512673.178.615191124116393644278.981.778.179.172.2
C51Vulva545448.157.73192021101.00.071.065.640.4
C52Vagina454541.847.9438191175.60.053.360.424.4
C53Cervix54854852.460.1633413021410770.457.262.162.347.8
C54Corpus uteri73573579.785.7991722571674091.895.483.480.265.0
C55Uterus unspecified14514529.732.7231229305187.977.032.915.42.9
C56Ovary1087108742.745.63081922562369559.447.442.238.522.1
C57Other female genital353547.151.61815740.051.249.549.468.0
C60Penis494967.383.38410121588.9104.067.1106.864.9
C61Prostate63963936.950.8249126827450.952.354.354.546.2
C62Testis11311374.377.570171110582.478.879.276.10.0
C64Kidney74348547.455.625844.949.11019020023511763.069.966.245.222.5
C65Renal pelvis674254.870.22544.048.235192812101.682.751.657.772.2
C66Ureter684843.751.82060.066.12531237101.0103.057.044.045.7
C67Urinary bladder1750135953.468.139143.251.3849235065656883.380.074.169.844.9
C68Other urinary organs261957.973.9716469102.034.955.261.661.9
C69Eye402867.974.11274.179.316884456.990.3107.461.779.9
C70-72Brain & nervous system190695834.837.994845.047.755125645346318356.259.243.926.216.2
C73Thyroid86819278.986.367687.590.84211541291224298.197.985.871.739.0
C74Adrenal gland1235557.963.56886.789.064132218688.295.073.431.682.7
C75Other endocrine33013171.577.119981.383.91764857381186.585.774.169.651.8
C81Hodgkin lymphoma995459.362.94566.069.74672419385.388.155.124.653.4
C82-85+C96Non-Hodgkin lymphoma127175832.236.751339.442.830314329535018050.153.938.631.523.2
C90Multiple myeloma23013619.823.19419.121.2133063893539.038.025.916.38.6
C91Lymphoid leukaemia33821031.034.012822.724.21732954602228.528.432.638.220.9
C92-94Myeloid leukaemia60534825.127.425725.726.7248741211184435.436.320.913.514.9
C95Leukaemia unspecified37720011.513.117710.711.41223465936317.412.113.48.07.7


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1991 and 1992-1995 (Shanghai, China)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)